Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43K Hold
50
﹤0.01% 2677
2026
Q1
$868 Hold
50
﹤0.01% 2708
2025
Q4
$942 Sell
50
-157
-76% -$2.63K ﹤0.01% 2664
2025
Q3
$3.01K Buy
207
+100
+93% +$1.43K ﹤0.01% 2262
2025
Q2
$2.09K Sell
107
-166
-61% -$2.95K ﹤0.01% 2363
2025
Q1
$4.85K Sell
273
-250
-48% -$5.38K ﹤0.01% 1913
2024
Q4
$11.2K Buy
+523
New +$12.7K ﹤0.01% 1596

Other funds holding CDNA

SBI Securities's CDNA Position: Q2 2026 in Review

SBI Securities held its CareDx (CDNA) position steady in Q2 2026 at 50 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

SBI Securities first reported a position in CDNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.2K in Q4 2024. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • SBI Securities held 50 shares of CareDx worth $1.43K as of Q2 2026.
  • SBI Securities left its CareDx share count unchanged in Q2 2026.
  • CareDx made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2677 holding.
  • SBI Securities first reported a position in CareDx in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's CareDx position peaked at $11.2K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.